Franklin Resources Inc. trimmed its position in shares of Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 8.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 155,415 shares of the company’s stock after selling 14,726 shares during the period. Franklin Resources Inc. owned 0.10% of Option Care Health worth $5,048,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also recently made changes to their positions in the company. USA Financial Formulas purchased a new position in shares of Option Care Health during the 2nd quarter valued at $26,000. Northwestern Mutual Wealth Management Co. lifted its holdings in Option Care Health by 1,492.9% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company’s stock valued at $31,000 after purchasing an additional 836 shares during the last quarter. Brooklyn Investment Group boosted its position in Option Care Health by 186.6% during the first quarter. Brooklyn Investment Group now owns 1,198 shares of the company’s stock worth $42,000 after purchasing an additional 780 shares during the period. Allworth Financial LP increased its stake in shares of Option Care Health by 126.6% in the second quarter. Allworth Financial LP now owns 2,237 shares of the company’s stock worth $73,000 after purchasing an additional 1,250 shares in the last quarter. Finally, Nisa Investment Advisors LLC increased its stake in shares of Option Care Health by 20.7% in the second quarter. Nisa Investment Advisors LLC now owns 3,701 shares of the company’s stock worth $120,000 after purchasing an additional 635 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors.
Option Care Health Price Performance
NASDAQ:OPCH opened at $30.94 on Tuesday. Option Care Health, Inc. has a 52-week low of $22.29 and a 52-week high of $35.53. The stock has a fifty day moving average of $28.03 and a 200 day moving average of $29.38. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52. The firm has a market capitalization of $4.91 billion, a price-to-earnings ratio of 24.75, a P/E/G ratio of 1.74 and a beta of 0.88.
Wall Street Analysts Forecast Growth
View Our Latest Analysis on Option Care Health
Insider Transactions at Option Care Health
In related news, Director Harry M. Jansen Kraemer, Jr. bought 38,000 shares of the company’s stock in a transaction on Monday, November 3rd. The stock was acquired at an average cost of $25.98 per share, for a total transaction of $987,240.00. Following the completion of the transaction, the director directly owned 413,390 shares in the company, valued at $10,739,872.20. This trade represents a 10.12% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Norman L. Wright purchased 3,411 shares of the business’s stock in a transaction on Tuesday, September 9th. The stock was bought at an average cost of $29.31 per share, with a total value of $99,976.41. Following the purchase, the director owned 15,501 shares in the company, valued at approximately $454,334.31. This represents a 28.21% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 0.64% of the company’s stock.
About Option Care Health
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Stories
- Five stocks we like better than Option Care Health
- How to start investing in penny stocks
- Up Over 20% in 2025, These 3 Stocks Are Boosting Buyback Capacity
- What Are the U.K. Market Holidays? How to Invest and Trade
- Congress Beat the Market Again—Here Are the 3 Stocks They Bought
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Go on a Shopping Spree With 3 Top Retail ETFs
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.
